Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 33

1.

High Frequency of β-Catenin Mutations in Mouse Hepatocellular Carcinomas Induced by a Nongenotoxic Constitutive Androstane Receptor Agonist.

Mattu S, Saliba C, Sulas P, Zavattari P, Perra A, Kowalik MA, Monga SP, Columbano A.

Am J Pathol. 2018 Nov;188(11):2497-2507. doi: 10.1016/j.ajpath.2018.07.022. Epub 2018 Sep 8.

PMID:
30201494
2.

Perindopril, fosinopril and losartan inhibited the progression of diethylnitrosamine-induced hepatocellular carcinoma in mice via the inactivation of nuclear transcription factor kappa-B.

Saber S, Mahmoud AAA, Goda R, Helal NS, El-Ahwany E, Abdelghany RH.

Toxicol Lett. 2018 Oct 1;295:32-40. doi: 10.1016/j.toxlet.2018.05.036. Epub 2018 May 31.

PMID:
29859236
3.

Selection of internal references for qRT-PCR assays of human hepatocellular carcinoma cell lines.

Liu Y, Qin Z, Cai L, Zou L, Zhao J, Zhong F.

Biosci Rep. 2017 Dec 22;37(6). pii: BSR20171281. doi: 10.1042/BSR20171281. Print 2017 Dec 22.

4.

MicroRNA-206 prevents the pathogenesis of hepatocellular carcinoma by modulating expression of met proto-oncogene and cyclin-dependent kinase 6 in mice.

Wu H, Tao J, Li X, Zhang T, Zhao L, Wang Y, Zhang L, Xiong J, Zeng Z, Zhan N, Steer CJ, Che L, Dong M, Wang X, Niu J, Li Z, Yan G, Chen X, Song G.

Hepatology. 2017 Dec;66(6):1952-1967. doi: 10.1002/hep.29374. Epub 2017 Oct 30.

5.

The NADPH Oxidase Inhibitor Apocynin Suppresses Preneoplastic Liver Foci of Rats.

Fuji S, Suzuki S, Naiki-Ito A, Kato H, Hayakawa M, Yamashita Y, Kuno T, Takahashi S.

Toxicol Pathol. 2017 Jun;45(4):544-550. doi: 10.1177/0192623317710013. Epub 2017 Jun 2.

PMID:
28573935
6.

Inhibitory effects of resveratrol on hepatitis B virus X protein-induced hepatocellular carcinoma.

Park S, Lim J, Kim JR, Cho S.

J Vet Sci. 2017 Dec 31;18(4):419-429. doi: 10.4142/jvs.2017.18.4.419.

7.

Bioinformatics prediction and experimental validation of microRNA-20a targeting Cyclin D1 in hepatocellular carcinoma.

Karimkhanloo H, Mohammadi-Yeganeh S, Ahsani Z, Paryan M.

Tumour Biol. 2017 Apr;39(4):1010428317698361. doi: 10.1177/1010428317698361.

PMID:
28378640
8.

Expression of transforming growth factor β1 promotes cholangiocarcinoma development and progression.

Huang CK, Aihara A, Iwagami Y, Yu T, Carlson R, Koga H, Kim M, Zou J, Casulli S, Wands JR.

Cancer Lett. 2016 Sep 28;380(1):153-62. doi: 10.1016/j.canlet.2016.05.038. Epub 2016 Jun 27.

9.

Soy Protein Isolate Protects Against Ethanol-Mediated Tumor Progression in Diethylnitrosamine-Treated Male Mice.

Mercer KE, Pulliam C, Hennings L, Lai K, Cleves M, Jones E, Drake RR, Ronis M.

Cancer Prev Res (Phila). 2016 Jun;9(6):466-75. doi: 10.1158/1940-6207.CAPR-15-0417. Epub 2016 Mar 22.

10.

The chemopreventive activity of butyrate-containing structured lipids in experimental rat hepatocarcinogenesis.

Heidor R, de Conti A, Ortega JF, Furtado KS, Silva RC, Tavares PE, Purgatto E, Ract JN, de Paiva SA, Gioielli LA, Pogribny IP, Moreno FS.

Mol Nutr Food Res. 2016 Feb;60(2):420-9. doi: 10.1002/mnfr.201500643. Epub 2015 Dec 2.

PMID:
26548572
11.

Accelerated hepatocellular carcinoma development in CUL4B transgenic mice.

Yuan J, Jiang B, Zhang A, Qian Y, Tan H, Gao J, Shao C, Gong Y.

Oncotarget. 2015 Jun 20;6(17):15209-21.

12.

Antitumour activity of an inhibitor of miR-34a in liver cancer with β-catenin-mutations.

Gougelet A, Sartor C, Bachelot L, Godard C, Marchiol C, Renault G, Tores F, Nitschke P, Cavard C, Terris B, Perret C, Colnot S.

Gut. 2016 Jun;65(6):1024-34. doi: 10.1136/gutjnl-2014-308969. Epub 2015 Mar 19.

13.

FAK is required for c-Met/β-catenin-driven hepatocarcinogenesis.

Shang N, Arteaga M, Zaidi A, Stauffer J, Cotler SJ, Zeleznik-Le NJ, Zhang J, Qiu W.

Hepatology. 2015 Jan;61(1):214-26. doi: 10.1002/hep.27402. Epub 2014 Nov 25.

14.

Anti-metastasis effect of fucoidan from Undaria pinnatifida sporophylls in mouse hepatocarcinoma Hca-F cells.

Wang P, Liu Z, Liu X, Teng H, Zhang C, Hou L, Zou X.

PLoS One. 2014 Aug 27;9(8):e106071. doi: 10.1371/journal.pone.0106071. eCollection 2014.

15.
16.

LRH-1 governs vital transcriptional programs in endocrine-sensitive and -resistant breast cancer cells.

Bianco S, Brunelle M, Jangal M, Magnani L, Gévry N.

Cancer Res. 2014 Apr 1;74(7):2015-25. doi: 10.1158/0008-5472.CAN-13-2351. Epub 2014 Feb 11.

18.

Panax ginseng exerts antiproliferative effects on rat hepatocarcinogenesis.

Kim H, Lee HJ, Kim DJ, Kim TM, Moon HS, Choi H.

Nutr Res. 2013 Sep;33(9):753-60. doi: 10.1016/j.nutres.2013.07.005. Epub 2013 Aug 15.

PMID:
24034575
19.

OCT4 increases BIRC5 and CCND1 expression and promotes cancer progression in hepatocellular carcinoma.

Cao L, Li C, Shen S, Yan Y, Ji W, Wang J, Qian H, Jiang X, Li Z, Wu M, Zhang Y, Su C.

BMC Cancer. 2013 Feb 22;13:82. doi: 10.1186/1471-2407-13-82.

20.

Dietary supplementation of silymarin is associated with decreased cell proliferation, increased apoptosis, and activation of detoxification system in hepatocellular carcinoma.

Gopalakrishnan R, Sundaram J, Sattu K, Pandi A, Thiruvengadam D.

Mol Cell Biochem. 2013 May;377(1-2):163-76. doi: 10.1007/s11010-013-1582-1. Epub 2013 Feb 9.

PMID:
23397134

Supplemental Content

Loading ...
Support Center